At5g10800 Antibody

What is AT5G10800 and why is it important to develop antibodies against it?

AT5G10800 is an RNA recognition motif (RRM)-containing protein found in Arabidopsis thaliana that functions in RNA binding, nucleotide binding, and nucleic acid binding processes . The protein is involved in RNA processing mechanisms and contains several important domains including SWAP/Surp, RNA polymerase II large subunit CTD, and RNA recognition motifs . Developing antibodies against AT5G10800 is crucial for investigating its expression patterns, subcellular localization, protein-protein interactions, and functional roles in plant RNA metabolism. The protein's substantial size (947 amino acids with a molecular weight of approximately 109 kDa) and involvement in fundamental cellular processes make it an important target for researchers studying plant RNA processing pathways and regulatory mechanisms . Antibodies against AT5G10800 enable visualization of the protein's distribution across different plant tissues and developmental stages, providing insights into its biological significance.

What types of antibodies are most suitable for detecting AT5G10800 in plant tissues?

When selecting antibodies for AT5G10800 detection in plant tissues, researchers should consider both polyclonal and monoclonal options based on their experimental requirements. Polyclonal antibodies, similar to those developed for other plant proteins, offer the advantage of recognizing multiple epitopes on the AT5G10800 protein, potentially enhancing detection sensitivity across different experimental conditions and plant species . These antibodies are particularly useful for initial characterization studies where robust signal detection is prioritized over epitope specificity. Monoclonal antibodies, while more challenging to develop, provide superior specificity by targeting a single epitope, making them valuable for discriminating between closely related RRM-containing proteins in plant samples . For plants with thick cell walls or complex tissues, antibody penetration should be optimized through appropriate fixation and permeabilization protocols. Given AT5G10800's nuclear localization (SUBAcon score of 1.000) , antibodies should be validated for their ability to efficiently access and detect nuclear proteins in plant cell preparations.

How can I confirm the specificity of an AT5G10800 antibody?

Confirming antibody specificity for AT5G10800 requires multiple validation approaches to ensure reliable experimental results. Western blot analysis using wild-type Arabidopsis tissue samples should reveal a single band at approximately 109 kDa, corresponding to the predicted molecular weight of AT5G10800 . This should be compared with negative controls using AT5G10800 knockout or knockdown plant lines, where the specific band should be absent or significantly reduced. Immunoprecipitation followed by mass spectrometry can provide definitive confirmation that the antibody is capturing the intended AT5G10800 protein rather than cross-reacting with other RRM-containing proteins. Pre-absorption tests, where the antibody is pre-incubated with purified AT5G10800 protein before immunostaining, should eliminate specific staining if the antibody is truly targeting AT5G10800. Additionally, immunofluorescence patterns should align with the expected nuclear localization of AT5G10800 as indicated by its SUBAcon score and computational predictions . For recombinant expression systems, parallel detection using both the AT5G10800 antibody and an epitope tag antibody (if the protein is tagged) should show overlapping signals.

What are the recommended storage conditions and handling practices for AT5G10800 antibodies?

Proper storage and handling of AT5G10800 antibodies are essential for maintaining their functionality and specificity throughout the research process. Like most research antibodies, AT5G10800 antibodies should be stored according to manufacturer recommendations, typically at -20°C for long-term storage with aliquoting to prevent freeze-thaw cycles that can degrade antibody quality . For working solutions, storage at 4°C with appropriate preservatives such as sodium azide (0.02%) can help maintain stability for several weeks. Avoiding repeated freeze-thaw cycles is particularly important as each cycle can reduce antibody activity by approximately 10-15%. Antibody dilutions should be prepared in high-quality, filtered buffers free of contaminants that could promote microbial growth or protein degradation. When handling the antibody, researchers should use low protein-binding tubes and pipette tips to prevent loss of antibody through non-specific adsorption. Prior to each use, antibody solutions should be gently mixed rather than vortexed to prevent protein denaturation and aggregation that could compromise binding capacity to AT5G10800 epitopes. Maintaining detailed records of antibody lot numbers, dilution factors, and experimental conditions will facilitate troubleshooting and ensure experimental reproducibility.

How can AT5G10800 antibodies be utilized in chromatin immunoprecipitation (ChIP) experiments?

Chromatin immunoprecipitation using AT5G10800 antibodies presents unique challenges and opportunities for investigating RNA-binding protein interactions with chromatin components. Since AT5G10800 functions as an RNA recognition motif-containing protein, ChIP protocols must be optimized to preserve both protein-DNA and protein-RNA interactions that may be relevant to its biological function . Standard ChIP protocols should be modified by incorporating RNA preservation steps during chromatin extraction, potentially using RNase inhibitors to maintain intact ribonucleoprotein complexes. Crosslinking conditions should be carefully optimized, with formaldehyde concentrations typically between 1-3% and incubation times adjusted to capture transient interactions without over-crosslinking. AT5G10800's nuclear localization (SUBAcon score of 1.000) makes it particularly suitable for ChIP applications, but researchers should verify antibody efficiency in immunoprecipitating crosslinked chromatin by performing pilot experiments with varying antibody concentrations . To distinguish between direct DNA interactions and RNA-mediated associations, researchers should consider performing parallel ChIP experiments with and without RNase treatment prior to immunoprecipitation. When analyzing ChIP-seq data, bioinformatic approaches should focus on identifying enrichment patterns correlating with transcriptional units or specific RNA processing sites that align with AT5G10800's presumed role in RNA metabolism.

What are the best approaches for using AT5G10800 antibodies in protein-protein interaction studies?

Protein-protein interaction studies using AT5G10800 antibodies require careful consideration of the protein's structural characteristics and cellular context. Co-immunoprecipitation (Co-IP) represents a primary approach, where AT5G10800 antibodies can capture the protein along with its interacting partners from plant cell lysates . For optimal results, researchers should prepare lysates under gentle conditions that preserve protein complexes, typically using non-ionic detergents like NP-40 or Triton X-100 at concentrations between 0.1-0.5%. Given AT5G10800's RNA-binding properties, including RNase treatment controls is essential to distinguish between direct protein-protein interactions and RNA-mediated associations . Proximity ligation assays (PLA) offer an alternative approach for visualizing AT5G10800 interactions within intact cells, providing spatial information about interaction domains. For this technique, researchers need pairs of antibodies (one targeting AT5G10800 and others targeting suspected interaction partners) that can work efficiently under PLA conditions. Bimolecular fluorescence complementation (BiFC) and Förster resonance energy transfer (FRET) approaches, while not directly using antibodies, can complement antibody-based interaction studies by confirming findings in living plant cells. When interpreting interaction data, researchers should consider AT5G10800's multiple domains (including SWAP/Surp and RNA recognition motifs) as potential interaction surfaces that might engage with different partner proteins in context-dependent manners .

How can I quantitatively measure AT5G10800 protein levels across different plant tissues or experimental conditions?

Quantitative measurement of AT5G10800 requires robust methodologies that account for the protein's characteristics and expression patterns. Quantitative Western blotting represents the most accessible approach, where AT5G10800 antibodies are used to detect the protein, with signal normalization to suitable housekeeping proteins like actin or GAPDH . For accurate quantification, researchers should establish a standard curve using recombinant AT5G10800 protein at known concentrations, ensuring the detection system remains in the linear range. Enzyme-linked immunosorbent assays (ELISA) can provide higher throughput quantification, but require developing sandwich ELISA protocols with two different AT5G10800 antibodies recognizing distinct epitopes, or a capture approach using anti-tag antibodies for recombinant systems. Mass spectrometry-based approaches like selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) offer the highest specificity and sensitivity, though they require significant technical expertise and specialized equipment. For these methods, AT5G10800 antibodies can be used in immunoprecipitation steps to enrich the target protein prior to mass spectrometric analysis. When comparing AT5G10800 levels across different plant tissues, researchers should consider the protein's reported expression patterns in embryos, sepals, pedicels, and flowers, as well as its developmental regulation during anthesis, globular stage, and petal differentiation . Statistical analysis of quantitative data should incorporate appropriate normalization methods and replicate designs to account for biological variability in AT5G10800 expression.

What considerations are important when using AT5G10800 antibodies for immunohistochemistry in plant tissues?

Immunohistochemical detection of AT5G10800 in plant tissues presents unique challenges that require specialized protocols and careful controls. Plant tissues require effective fixation that balances epitope preservation with adequate tissue penetration; paraformaldehyde (3-4%) is typically suitable, though fixation times may need optimization depending on tissue type . Antigen retrieval steps are often necessary due to extensive cross-linking in plant cell walls and should be empirically optimized for AT5G10800 detection. Given the protein's nuclear localization (SUBAcon score of 1.000), cell permeabilization is crucial, with methods like detergent treatment (0.1-0.3% Triton X-100) or enzymatic digestion of cell walls improving antibody access to nuclear compartments . Autofluorescence represents a significant challenge in plant tissues; pre-treatments with reducing agents like sodium borohydride or Sudan Black B can reduce this interference. Specific detection of AT5G10800 should be confirmed through comparison with tissues from knockout or knockdown plants, alongside peptide competition assays where the antibody is pre-incubated with the immunizing peptide. When interpreting immunohistochemical results, researchers should correlate staining patterns with AT5G10800's reported expression in specific tissues, including embryos, sepals, pedicels, and flowers, and consider developmental timing based on its known expression during anthesis, globular stage, and petal differentiation phases . Multi-label immunohistochemistry combining AT5G10800 antibodies with markers for specific cellular compartments can provide valuable insights into the protein's precise subcellular distribution.

What are common issues encountered when using AT5G10800 antibodies in Western blotting, and how can they be resolved?

Western blotting with AT5G10800 antibodies can present several technical challenges that require systematic troubleshooting. A common issue is weak or absent signal, which may result from low AT5G10800 expression levels, particularly in tissues other than those with documented expression (embryos, sepals, pedicels, and flowers) . This can be addressed by increasing sample concentration, optimizing protein extraction methods for nuclear proteins, extending primary antibody incubation time (overnight at 4°C), or using signal enhancement systems like biotin-streptavidin amplification. Multiple or unexpected bands may indicate cross-reactivity with other RRM-containing proteins, as AT5G10800 shares sequence similarities with other proteins in this family . To resolve this, researchers should increase washing stringency, optimize antibody dilution, or perform preabsorption with recombinant proteins containing similar domains. High background often results from non-specific antibody binding, which can be minimized by using optimized blocking solutions (5% non-fat milk or BSA) and adding detergents like Tween-20 (0.1%) to washing buffers. The protein's high molecular weight (109 kDa) may cause inefficient transfer, resulting in weak signals for intact AT5G10800 . This can be addressed by extending transfer time, using lower percentage gels (7-8%), or implementing specialized transfer conditions for high molecular weight proteins. Post-translational modifications or proteolytic processing may cause band shifts or multiple bands; these can be characterized by treatment with phosphatases, deglycosylation enzymes, or protease inhibitors during sample preparation.

How should I interpret conflicting results between different detection methods using AT5G10800 antibodies?

Conflicting results between different detection methods represent a common challenge in AT5G10800 research that requires careful analysis and interpretation. When Western blotting and immunohistochemistry yield discrepant results, researchers should consider that each method detects proteins under different conditions — Western blotting under denaturing conditions versus immunohistochemistry where epitopes remain in their native conformation . Differences may indicate epitope masking in one condition, perhaps due to AT5G10800's interaction with other proteins or RNA in its native state, given its RNA-binding function . Disparities between immunofluorescence localization and fractionation studies might result from extraction efficiency issues, as nuclear proteins like AT5G10800 (SUBAcon score of 1.000) may require specialized extraction protocols . When mass spectrometry fails to detect AT5G10800 despite positive antibody-based results, consider sensitivity thresholds or incomplete tryptic digestion of this large protein (947 amino acids). For resolution, researchers should implement cross-validation strategies using alternative antibodies targeting different AT5G10800 epitopes, complement antibody-based methods with non-antibody approaches like fluorescent protein tagging, and employ genetic controls including AT5G10800 knockout/knockdown lines. A comprehensive validation matrix documenting antibody performance across multiple techniques can help identify pattern-consistent findings versus technique-specific artifacts. Finally, researchers should consider biological context, as AT5G10800 expression varies across tissues and developmental stages, potentially explaining seemingly contradictory results from different experimental conditions .

How can I distinguish between specific and non-specific signals when using AT5G10800 antibodies in immunoprecipitation?

Distinguishing specific from non-specific signals in AT5G10800 immunoprecipitation experiments requires rigorous controls and analytical approaches. A fundamental control involves parallel immunoprecipitation using non-specific antibodies of the same isotype and concentration, which should pull down significantly less AT5G10800 than the specific antibody . Genetic controls using tissues from AT5G10800 knockout or knockdown plants represent the gold standard, as any signal obtained from these samples must be non-specific. Pre-clearing lysates with protein A/G beads before adding the AT5G10800 antibody reduces non-specific binding of sticky proteins to the beads themselves. Competition assays, where excess recombinant AT5G10800 or immunizing peptide is added to the immunoprecipitation reaction, should reduce specific signals while leaving non-specific interactions unchanged. Given AT5G10800's RNA-binding properties, researchers should include RNase treatment controls to identify RNA-dependent interactions that might appear as non-specific binding . For mass spectrometry analysis of immunoprecipitated complexes, quantitative approaches like stable isotope labeling (SILAC) or tandem mass tag (TMT) labeling can differentiate between enriched proteins (likely specific) and background contaminants by comparing abundance ratios between specific antibody and control conditions. Statistical thresholds should be established for fold-enrichment and p-values when analyzing immunoprecipitation-mass spectrometry data to systematically distinguish specific interactors from background. Researchers should also consider AT5G10800's predicted interactions based on its domains (SWAP/Surp, RNA recognition motif) and subcellular localization (nucleus) when evaluating the biological plausibility of potential interaction partners .

What factors might affect the reproducibility of experiments using AT5G10800 antibodies?

Experimental reproducibility with AT5G10800 antibodies depends on multiple controllable and uncontrollable factors that researchers should systematically address. Antibody lot-to-lot variability represents a primary concern, as different production batches may contain varying concentrations of specific antibodies or different subpopulations of polyclonal antibodies . To mitigate this, researchers should record lot numbers, purchase sufficient quantities of a single lot for long-term studies, and revalidate new lots against standards. Plant growth conditions significantly impact AT5G10800 expression patterns, as this protein shows developmental regulation during anthesis, globular stage, and petal differentiation . Standardizing growth parameters (light intensity, photoperiod, temperature, humidity) and harvesting tissues at precisely defined developmental stages enhances reproducibility. Sample preparation variables, including buffer composition, protease/phosphatase inhibitors, and extraction procedures, critically influence protein integrity and antibody accessibility, particularly for nuclear proteins like AT5G10800 . Technical factors such as incubation times, temperatures, antibody dilutions, and detection methods should be meticulously documented and controlled. Cross-laboratory reproducibility challenges can be addressed through detailed methods reporting, including seemingly minor parameters often omitted from publications. When troubleshooting reproducibility issues, researchers should implement a systematic approach that sequentially examines antibody performance, sample quality, technical variables, and biological factors. Creating standard operating procedures (SOPs) for AT5G10800 detection methods, with positive and negative controls run alongside experimental samples, provides a framework for distinguishing technical variability from genuine biological effects.

What are the best protein extraction methods for AT5G10800 detection in plant tissues?

Optimal protein extraction for AT5G10800 detection requires specialized approaches that address the challenges of plant tissues and nuclear protein isolation. Nuclear extraction protocols are particularly important, given AT5G10800's nuclear localization (SUBAcon score of 1.000) . These typically involve initial tissue homogenization in a buffer containing detergent (0.5-1% Triton X-100) to disrupt cell membranes while preserving nuclear integrity, followed by nuclear isolation through differential centrifugation. RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0) supplemented with nuclease inhibitors is effective for subsequent extraction of nuclear proteins like AT5G10800. Plant-specific challenges include high levels of interfering compounds such as polyphenols, polysaccharides, and proteases that can degrade proteins and interfere with antibody binding. These can be addressed by including polyvinylpolypyrrolidone (PVPP, 2-5%) to adsorb phenolic compounds, high concentrations of protease inhibitors (complete protease inhibitor cocktail at 2X recommended concentration), and reducing agents like dithiothreitol (DTT, 5-10 mM) to prevent oxidation of sensitive proteins. For AT5G10800 specifically, including RNase inhibitors may be important to preserve potential protein-RNA complexes that could affect antibody epitope accessibility . Extraction efficiency should be verified through multiple approaches, including Western blotting of different cellular fractions and immunofluorescence microscopy to confirm depletion of nuclear signal after extraction. Quantitative recovery can be assessed by spiking samples with known quantities of recombinant AT5G10800 protein and measuring recovery percentages after the extraction procedure.

How should experimental controls be designed for AT5G10800 antibody validation?

Comprehensive validation of AT5G10800 antibodies requires a multi-tiered control strategy that addresses specificity, sensitivity, and reproducibility considerations. Genetic controls represent the gold standard, ideally including AT5G10800 knockout lines generated through CRISPR-Cas9 or T-DNA insertion, which should show complete absence of specific signal . If knockout plants are not viable due to essential functions, knockdown lines created through RNAi or inducible silencing systems provide alternative negative controls with reduced signal. Recombinant protein controls should include both full-length AT5G10800 and fragments representing different domains (SWAP/Surp, RNA recognition motif) to map epitope specificity . Epitope competition assays, where the antibody is pre-incubated with excess immunizing peptide or recombinant protein before application, should eliminate specific binding while leaving non-specific interactions unaffected. Cross-reactivity controls should assess antibody performance against other RRM-containing proteins in Arabidopsis, particularly AT5G25060.1, which is identified as the best protein match to AT5G10800 . Technical negative controls should include omission of primary antibody, use of pre-immune serum (for polyclonal antibodies), and isotype-matched irrelevant antibodies (for monoclonals). Positive controls should include tissues with known high expression of AT5G10800, such as embryos, sepals, pedicels, and flowers at specific developmental stages . Quantitative validation should establish detection limits, linear range, and reproducibility metrics for each application (Western blotting, immunoprecipitation, immunohistochemistry) using standard curves with recombinant protein. Documentation of validation results in a standardized format facilitates comparison across different antibody lots and experimental conditions.

What considerations are important when designing experiments to study post-translational modifications of AT5G10800?

Investigating post-translational modifications (PTMs) of AT5G10800 requires specialized experimental approaches that preserve and detect these often transient and substoichiometric modifications. Protein extraction conditions must be optimized to preserve PTMs by including appropriate inhibitors: phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) for phosphorylation studies, deubiquitinase inhibitors (N-ethylmaleimide) for ubiquitination analysis, and proteasome inhibitors (MG132) to prevent degradation of modified forms . Specialized antibodies that recognize specific PTMs (phospho-specific, acetylation-specific) on AT5G10800 may be required, though their development presents technical challenges due to the need for site-specific modification information. Alternative approaches include using generic PTM antibodies (anti-phosphotyrosine, anti-ubiquitin) for immunoprecipitation followed by AT5G10800-specific detection. Mass spectrometry represents the most comprehensive approach for PTM identification, typically involving enrichment of AT5G10800 through immunoprecipitation, followed by protease digestion and LC-MS/MS analysis. Researchers should consider potential PTM crosstalk, where one modification influences others, requiring simultaneous analysis of multiple PTM types. Biological contexts that might trigger AT5G10800 modifications should be investigated, such as stress conditions, developmental transitions (particularly during the known expression windows like anthesis and petal differentiation), or exposure to hormones . Functional validation of identified PTMs can be accomplished through site-directed mutagenesis of modified residues to non-modifiable variants, followed by phenotypic analysis in transgenic plants. Temporal dynamics of AT5G10800 modifications should be assessed through time-course experiments with synchronized plant populations or inducible expression systems.

What approaches are recommended for developing new antibodies against specific domains of AT5G10800?

Developing domain-specific antibodies for AT5G10800 requires strategic approaches that consider the protein's structure, sequence conservation, and experimental applications. Epitope selection represents the critical first step, with bioinformatic analysis identifying regions within specific domains (SWAP/Surp, RNA recognition motif, RNA polymerase II CTD) that combine high antigenicity with minimal sequence similarity to other plant proteins . Ideal epitopes should be surface-exposed in the native protein, avoiding hydrophobic core regions that would be inaccessible in non-denaturing applications. For domain-specific antibodies, researchers should target unique regions within each domain rather than conserved motifs that might cross-react with similar domains in other proteins. Peptide-based immunization offers advantages for domain specificity, where synthetic peptides (typically 15-20 amino acids) corresponding to selected epitopes are conjugated to carrier proteins like KLH or BSA before immunization . For conformational epitopes within domains, recombinant protein fragments expressing individual domains may provide better immunogens that maintain secondary structure elements. Host species selection should consider phylogenetic distance from plants, with rabbits, guinea pigs, or chickens often providing strong responses against plant proteins. Purification strategies should include affinity chromatography using the immunizing peptide or domain fragment, potentially followed by negative selection against homologous domains from related proteins to remove cross-reactive antibodies. Validation processes should specifically assess domain selectivity by testing against recombinant AT5G10800 fragments containing different domains and against related RRM-containing proteins . Application-specific validation is essential, as domain-specific antibodies might perform differently in various techniques depending on epitope accessibility in native versus denatured conformations.